Research from Tech in Asia, Tech in Asia

Tech in Asia

Research from Tech in Asia

Tech in Asia (YC W15) is the largest English-language technology media company that focuses on Asia. From the latest news to the hottest trends and the boldest startups to the strongest titans, we cover everything tech in the region. Our goal is to build and serve Asia’s tech and startup community.

News from Tech in Asia

Private Capital Markets

<ul><li><a href="https://www.amili.asia/" target="_blank" rel="noopener">Amili</a>, a Singapore-based gut microbiome company, has raised an undisclosed sum from East Ventures in a new funding round.</li><li>The fresh funds will be used for its expansion to Indonesia, focusing on addressing gut health issues specific to the local context.</li><li>Amili’s current offerings include gut microbiome sequencing services for healthcare professionals and probiotic formulations tailored to Asian consumers. Microbiome sequencing is a method for studying bacteria to fuel research on disease protection.</li></ul>

Amili, a Singapore-based gut microbiome company, has raised an undisclosed sum from East Ventures in a new funding round.The fresh funds will be used for its expansion to Indonesia, focusing on addressing gut health issues specific to the local context.Amili’s current offerings include gut microbiome sequencing services for healthcare professionals and probiotic formulations tailored to Asian consumers. Microbiome sequencing is a method for studying bacteria to fuel research on disease protection.

East Ventures Backs SG Microbiome Firm Bound for Indonesia

Singapore

Amili Pte. Ltd. operates as a biotech. The Company specializes in developing advanced microbiome human health energy food and creating critical compounds such as neurotransmitters, enzymes, and vitamins as well as provides research and testing services. Amili serves customers in Singapore.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Amili (2082692D SP)

East Ventures Backs SG Microbiome Firm Bound for Indonesia

Amili, a Singapore-based gut microbiome company, has raised an undisclosed sum from East Ventures in a new funding round. The fresh funds will be...

Tech in Asia

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)